Stability of activated partial thromboplastin time (APTT) test under different storage conditions

被引:10
作者
Awad, Mohammed A. [1 ]
Eldeen, Omar A. Sharaf [1 ]
Ibrahim, Hoda A. [1 ]
机构
[1] Mansoura Fac Med, Dept Clin Pathol, Hematol Unit, Mansoura, Egypt
关键词
APTT; factor VIII; heparin therapy; plasma;
D O I
10.1080/10245330500397752
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
We designed this study to assess the effect of storage time and temperature on the activated partial thromboplastin time (APTT) test and plasma activity of factor VIII (FVIII). A total of 71 subjects, comprising 34 healthy controls and 37 patients receiving unfractionated heparin were enrolled. After centrifugation of collected specimens aliquots of plasma were stored at room temperature (20-22 degrees C), refrigerated at 2-6 degrees C and frozen at -40 degrees C. Determination of APTT and plasma activity of FVIII were performed immediately after sampling (zero time) and after 6, 12 and 24 h. We found no significant difference in APTT after 6 h at room temperature and 4 degrees C compared to zero time values (P > 0.05) in control group, while APTT was significantly changed at other storage conditions. With regard APTT test in patients on heparin therapy and samples for FVIII activity in healthy subjects; there was a statistically significant change in their results after 6, 12 and 24 h at room temperature, 4 and -40 degrees C compared to zero time value (P < 0.05). Our data demonstrate that the APTT test can be done within 6 h when stored at room temperature and 4 degrees C without change in the result in healthy subjects. APTT test in patients on heparin therapy and samples for FVIII test in healthy subjects must be done immediately and without delay to avoid reduction in their activities.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 20 条
[1]
The effect of time and temperature variables on routine coagulation tests [J].
Adcock, D ;
Kressin, D ;
Marlar, RA .
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (06) :463-470
[2]
Blood coagulation factor VIII: An overview [J].
Bhopale, GM ;
Nanda, RK .
JOURNAL OF BIOSCIENCES, 2003, 28 (06) :783-789
[3]
BRANDT JT, 1991, ARCH PATHOL LAB MED, V115, P109
[4]
Bussey H, 2004, PHARMACOTHERAPY, V24, P103
[5]
DUNCAN EM, 1994, THROMB HAEMOSTASIS, V72, P84
[6]
Francis JL, 2004, PHARMACOTHERAPY, V24, P108
[7]
HASSETT AC, 1999, ARCH PATHOL LAB MED, V122, P768
[8]
Influence of time and temperature on coagulation analytes in stored plasma [J].
Heil, W ;
Grunewald, R ;
Amend, M ;
Heins, M .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (07) :459-462
[9]
Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety [J].
Hirsh, J ;
Warkentin, TE ;
Shaughnessy, SG ;
Anand, SS ;
Halperin, JL ;
Raschke, R ;
Granger, C ;
Ohman, EM ;
Dalen, JE .
CHEST, 2001, 119 (01) :64S-94S
[10]
BIOLOGICAL REGULATION OF FACTOR-VIII ACTIVITY [J].
KAUFMAN, RJ .
ANNUAL REVIEW OF MEDICINE, 1992, 43 :325-339